Electric current test may forecast lung surgery complications

NCT ID NCT06796816

First seen Jul 17, 2026 · Last updated Jul 17, 2026

Summary

This study investigates whether bioimpedance analysis, a quick and painless test that measures body water and muscle mass using a weak electrical current, can help predict complications after lung cancer surgery. Researchers will compare these measurements with standard CT scans and track outcomes like irregular heartbeat, collapsed lung, and fluid buildup in 1,000 patients. The goal is to see if this simple tool can identify high-risk patients before surgery.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Bioelectrical Impedance Vector Analysis (BIVA) - a non-invasive test that measures body composition and hydration using a weak electrical current.
What this could lead to
If successful, this could help doctors better predict which patients are at risk for complications after lung surgery, leading to more personalized care.
What could go wrong
This is an observational study, not a treatment trial. It may find no strong link between bioimpedance measures and outcomes, limiting its practical use.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ADENOCARCINOMA OF LUNG are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Adenocarcinoma of Lung lung adenocarcinoma lung neoplasm Sarcopenia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • AUSL IRCCS di Reggio Emilia

    Reggio Emilia, Italy

More trials for these conditions

Other studies related to the condition(s) this trial covers.